GRI Bio, Inc. (GRI)
1.93
+0.09
(+4.89%)
USD |
NASDAQ |
Sep 18, 16:00
1.90
-0.03
(-1.55%)
After-Hours: 20:00
GRI Bio Total Assets (Quarterly) : 11.38M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 11.38M |
| March 31, 2026 | 11.34M |
| December 31, 2025 | 8.666M |
| September 30, 2025 | 4.782M |
| June 30, 2025 | 5.675M |
| March 31, 2025 | 4.042M |
| December 31, 2024 | 5.739M |
| September 30, 2024 | 5.459M |
| June 30, 2024 | 7.031M |
| March 31, 2024 | 4.587M |
| December 31, 2023 | 2.956M |
| September 30, 2023 | 4.404M |
| June 30, 2023 | 5.642M |
| March 31, 2023 | 2.097M |
| Date | Value |
|---|---|
| December 31, 2022 | 0.383M |
| September 30, 2022 | 5.569M |
| June 30, 2022 | 8.007M |
| March 31, 2022 | 5.944M |
| December 31, 2021 | 8.335M |
| September 30, 2021 | 10.14M |
| June 30, 2021 | 11.65M |
| March 31, 2021 | 14.60M |
| December 31, 2020 | 0.955M |
| September 30, 2020 | 1.607M |
| June 30, 2020 | 2.435M |
| March 31, 2020 | |
| December 31, 2019 | 4.276M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 1.743B |
| Alnylam Pharmaceuticals, Inc. | 5.559B |
| Anika Therapeutics, Inc. | 183.47M |
| Savara, Inc. | 192.14M |
| Vericel Corp. | 502.87M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 1.10M |
| Shareholders Equity (Quarterly) | 10.28M |
| Debt to Equity Ratio | 0.0043 |
| Current Ratio | 10.30 |
| Net Debt Paydown Yield | 0.33% |